Cell Death Pathways Associated with Photodynamic Therapy: An Update.
David Kessel1, Nancy L Oleinick2
1Wayne State University School of Medicine, Detroit, MI.
Photochemistry and Photobiology
|November 17, 2017
Summary
Photodynamic therapy (PDT) shows promise for cancer treatment. Optimizing PDT involves targeting specific subcellular organelles to enhance tumor eradication and overcome treatment resistance.
Area of Science:
- Oncology
- Photomedicine
- Cancer Therapeutics
Background:
- Photodynamic therapy (PDT) utilizes light to sensitize malignant tissues, offering selective cancer treatment.
- Challenges in PDT include light/drug delivery variations, reduced efficacy in hypoxic areas, and potential for increased tumor aggressiveness in surviving cells.
- Effective direct tumor eradication is a primary goal for improving PDT outcomes.
Purpose of the Study:
- To explore strategies for optimizing photodynamic therapy efficacy.
- To highlight subcellular targeting as a crucial factor for ideal photosensitizing agents.
- To discuss perspectives on enhancing PDT by initiating cell death pathways through photodamage to specific organelles.
Main Methods:
- Review of existing literature on photodynamic therapy.
- Analysis of factors affecting PDT efficacy, including light and drug delivery, hypoxia, and cellular response.
- Consideration of subcellular localization and organelle-specific photodamage for therapeutic improvement.
Main Results:
- Subcellular targeting is proposed as a key property for ideal photosensitizers, alongside traditional formulation, pharmacologic, and photophysical characteristics.
- Understanding death pathways initiated by photodamage to specific subcellular organelles can guide optimization strategies.
- Addressing limitations like hypoxia and drug delivery is essential for maximizing PDT's impact.
Conclusions:
- Optimizing PDT requires a multifaceted approach, including enhancing direct tumor eradication.
- Subcellular targeting offers a promising avenue to improve photosensitizer efficacy and selectivity.
- Further research into organelle-specific photodamage can lead to more effective cancer treatments using PDT.
Related Concept Videos
01:30Overview of Cell Death
10.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.4K
01:31The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
01:17The Extrinsic Apoptotic Pathway
8.8K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.8K
01:30Apoptosis
15.4K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
15.4K
01:16Necrosis
6.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.8K
01:18Autophagic Cell Death
4.7K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K